1887

Abstract

In this study, we aimed to characterize the epitope recognized by the neutralizing 17H23 mAb directed against the E2 glycoprotein of most of salmonid alphavirus (SAV) subtypes and widely used in several laboratories to routinely diagnose SAV. We hypothesized that the 17H23 epitope was located in the major domain B, previously identified in the E2 of mammalian alphaviruses as the domain recognized by most of the E2 neutralizing mAbs. Indeed, the SAV E2 domain B counterpart is contained in the protein domain previously characterized as being recognized by mAb 17H23. Thus, to precisely characterize the 17H23 epitope, we developed an alanine scanning mutagenesis approach coupled with the generation of the respective recombinant SAV (rSAV) by using the available infectious cDNA. Ten mutant rSAVs termed A–J from E2 aa 223–236 were produced and characterized using indirect immunofluorescence assays on virus-infected cells with mAbs 17H23, 51B8 (another non-neutralizing anti-E2 mAb) and 19F3 directed against the non-structural protein nsp1. Two of the mutant rSAVs (G and H) escaped neutralization by mAb 17H23. In addition, we showed that when juvenile trout were infected by bath immersion with the rSAV mutants, some of them were either totally (D, E and G) or partially (H) attenuated. Together, the data from the and experiments indicated that the putative 17H23 amino acid sequence epitope comprised the short amino acid sequence FTSDS.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000411
2016-04-01
2020-01-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/4/893.html?itemId=/content/journal/jgv/10.1099/jgv.0.000411&mimeType=html&fmt=ahah

References

  1. Anonymous 1985; Maladie du sommeil et pollutions expérimentales Technical report no. 118. Laboratoire National de Pathologie des Animaux Aquatiques, CNEVA, Brest, France.
    [Google Scholar]
  2. Biacchesi S., Jouvion G., Mérour E., Boukadiri A., Desdouits M., Ozden S., Huerre M., Ceccaldi P. E., Brémont M.. 2015; Rainbow trout (Oncorhynchus mykiss) muscle satellite cells are targets of salmonid alphavirus infection. Vet Res47:9[CrossRef]
    [Google Scholar]
  3. Boscher S. K., McLoughlin M., Le Ven A., Cabon J., Baud M., Castric J.. 2006; Experimental transmission of sleeping disease in one-year-old rainbow trout, Oncorhynchus mykiss (Walbaum), induced by sleeping disease virus. J Fish Dis29:263–273 [CrossRef][PubMed]
    [Google Scholar]
  4. Boucher P.. 1995; Etiologie et pathogénie de la Maladie du Pancréas et de la Maladie du Sommeil chez les Salmonidés d'élevage Thesis, University of Rennes 1, Rennes, France.
    [Google Scholar]
  5. Boucher P., Baudin-Laurencin F.. 1994; Sleeping disease of salmonids. Bull Eur Assoc Fish Pathol14:179–180
    [Google Scholar]
  6. Boucher P., Baudin-Laurencin F. B.. 1996; Sleeping disease and pancreas disease: comparative histopathology and acquired cross-protection. J Fish Dis19:303–310 [CrossRef]
    [Google Scholar]
  7. Bratland A., Nylund A.. 2009; Studies on the possibility of vertical transmission of Norwegian salmonid Alphavirus in production of Atlantic salmon in Norway. J Aquat Anim Health21:173–178 [CrossRef][PubMed]
    [Google Scholar]
  8. Fox J. M., Long F., Edeling M. A., Lin H., van Duijl-Richter M. K., Fong R. H., Kahle K. M., Smit J. M., Jin J., other authors. 2015; Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress. Cell163:1095–1107 [CrossRef][PubMed]
    [Google Scholar]
  9. Fringuelli E., Rowley H. M., Wilson J. C., Hunter R., Rodger H., Graham D. A.. 2008; Phylogenetic analyses and molecular epidemiology of European salmonid alphaviruses (SAV) based on partial E2 and nsP3 gene nucleotide sequences. J Fish Dis31:811–823 [CrossRef][PubMed]
    [Google Scholar]
  10. Graham D. A., Rowley H. R., Frost P.. 2014; Cross-neutralization studies with salmonid alphavirus subtype 1-6 strains: results with sera from experimental studies and natural infections. J Fish Dis37:683–691 [CrossRef][PubMed]
    [Google Scholar]
  11. Kongtorp R. T., Stene A., Andreassen P. A., Aspehaug V., Graham D. A., Lyngstad T. M., Olsen A. B., Olsen R. S., Sandberg M., other authors. 2010; Lack of evidence for vertical transmission of SAV 3 using gametes of Atlantic salmon, Salmo salar L. exposed by natural and experimental routes. J Fish Dis33:879–888 [CrossRef][PubMed]
    [Google Scholar]
  12. McLoughlin M. F., Graham D. A.. 2007; Alphavirus infections in salmonids – a review. J Fish Dis30:511–531 [CrossRef][PubMed]
    [Google Scholar]
  13. McLoughlin M. F., Nelson R. T., Rowley H. M., Cox D. I., Grant A. N.. 1996; Experimental pancreas disease in Atlantic salmon Salmo salar post-smolts induced by salmon pancreas disease virus (SPDV). Dis Aquat Org26:117–124[CrossRef]
    [Google Scholar]
  14. Mérour E., Brémont M.. 2015; Vaccination against diseases caused by salmonid alphavirus. In Fish Vaccination pp334–340Edited by Gudding R., Lillehaug A., Evensen Ø.. Oxford, UK: John Wiley & Sons;
    [Google Scholar]
  15. Mérour E., Lamoureux A., Bernard J., Biacchesi S., Brémont M.. 2013; A fully attenuated recombinant salmonid alphavirus becomes pathogenic through a single amino acid change in the E2 glycoprotein. J Virol87:6027–6030 [CrossRef][PubMed]
    [Google Scholar]
  16. Moriette C., LeBerre M., Boscher S. K., Castric J., Brémont M.. 2005; Characterization and mapping of monoclonal antibodies against the sleeping disease virus, an aquatic alphavirus. J Gen Virol86:3119–3127 [CrossRef][PubMed]
    [Google Scholar]
  17. Moriette C., Leberre M., Lamoureux A., Lai T. L., Brémont M.. 2006; Recovery of a recombinant salmonid alphavirus fully attenuated and protective for rainbow trout. J Virol80:4088–4098 [CrossRef][PubMed]
    [Google Scholar]
  18. Pal P., Fox J. M., Hawman D. W., Huang Y. J., Messaoudi I., Kreklywich C., Denton M., Legasse A. W., Smith P. P., other authors. 2014; Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes. J Virol88:8213–8226 [CrossRef][PubMed]
    [Google Scholar]
  19. Porta J., Jose J., Roehrig J. T., Blair C. D., Kuhn R. J., Rossmann M. G.. 2014; Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies. J Virol88:9616–9623 [CrossRef][PubMed]
    [Google Scholar]
  20. Snyder A. J., Sokoloski K. J., Mukhopadhyay S.. 2012; Mutating conserved cysteines in the alphavirus E2 glycoprotein causes virus-specific assembly defects. J Virol86:3100–3111 [CrossRef][PubMed]
    [Google Scholar]
  21. Voss J. E., Vaney M. C., Duquerroy S., Vonrhein C., Girard-Blanc C., Crublet E., Thompson A., Bricogne G., Rey F. A.. 2010; Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature468:709–712 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000411
Loading
/content/journal/jgv/10.1099/jgv.0.000411
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error